Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

microRNAs and Personalized Medicine: Evaluating Their Potential as Cancer Biomarkers.

Saumet A, Lecellier CH.

Adv Exp Med Biol. 2015;888:5-15. doi: 10.1007/978-3-319-22671-2_2. Review.

PMID:
26663176
2.

The potential of microRNAs in personalized medicine against cancers.

Saumet A, Mathelier A, Lecellier CH.

Biomed Res Int. 2014;2014:642916. doi: 10.1155/2014/642916. Epub 2014 Aug 28. Review.

3.

All-trans retinoic acid (ATRA) induces miR-23a expression, decreases CTSC expression and granzyme B activity leading to impaired NK cell cytotoxicity.

Sanchez-Martínez D, Krzywinska E, Rathore MG, Saumet A, Cornillon A, Lopez-Royuela N, Martínez-Lostao L, Ramirez-Labrada A, Lu ZY, Rossi JF, Fernández-Orth D, Escorza S, Anel A, Lecellier CH, Pardo J, Villalba M.

Int J Biochem Cell Biol. 2014 Apr;49:42-52. doi: 10.1016/j.biocel.2014.01.003. Epub 2014 Jan 15.

PMID:
24440757
4.

RNAi and retroviruses: are they in RISC?

Vasselon T, Bouttier M, Saumet A, Lecellier CH.

Biomol Concepts. 2013 Feb;4(1):43-52. doi: 10.1515/bmc-2012-0041. Review.

PMID:
25436564
5.

Estrogen and retinoic acid antagonistically regulate several microRNA genes to control aerobic glycolysis in breast cancer cells.

Saumet A, Vetter G, Bouttier M, Antoine E, Roubert C, Orsetti B, Theillet C, Lecellier CH.

Mol Biosyst. 2012 Oct 30;8(12):3242-53. doi: 10.1039/c2mb25298h.

PMID:
23064179
6.

The NF-κB member p65 controls glutamine metabolism through miR-23a.

Rathore MG, Saumet A, Rossi JF, de Bettignies C, Tempé D, Lecellier CH, Villalba M.

Int J Biochem Cell Biol. 2012 Sep;44(9):1448-56. doi: 10.1016/j.biocel.2012.05.011. Epub 2012 May 24.

PMID:
22634383
7.

Retroviral GAG proteins recruit AGO2 on viral RNAs without affecting RNA accumulation and translation.

Bouttier M, Saumet A, Peter M, Courgnaud V, Schmidt U, Cazevieille C, Bertrand E, Lecellier CH.

Nucleic Acids Res. 2012 Jan;40(2):775-86. doi: 10.1093/nar/gkr762. Epub 2011 Sep 24.

8.

MIR@NT@N: a framework integrating transcription factors, microRNAs and their targets to identify sub-network motifs in a meta-regulation network model.

Le Béchec A, Portales-Casamar E, Vetter G, Moes M, Zindy PJ, Saumet A, Arenillas D, Theillet C, Wasserman WW, Lecellier CH, Friederich E.

BMC Bioinformatics. 2011 Mar 4;12:67. doi: 10.1186/1471-2105-12-67.

9.

Temozolomide-based dry powder formulations for lung tumor-related inhalation treatment.

Wauthoz N, Deleuze P, Saumet A, Duret C, Kiss R, Amighi K.

Pharm Res. 2011 Apr;28(4):762-75. doi: 10.1007/s11095-010-0329-x. Epub 2010 Nov 30.

PMID:
21116692
10.

miR-661 expression in SNAI1-induced epithelial to mesenchymal transition contributes to breast cancer cell invasion by targeting Nectin-1 and StarD10 messengers.

Vetter G, Saumet A, Moes M, Vallar L, Le Béchec A, Laurini C, Sabbah M, Arar K, Theillet C, Lecellier CH, Friederich E.

Oncogene. 2010 Aug 5;29(31):4436-48. doi: 10.1038/onc.2010.181. Epub 2010 Jun 14.

11.

Transcriptional repression of microRNA genes by PML-RARA increases expression of key cancer proteins in acute promyelocytic leukemia.

Saumet A, Vetter G, Bouttier M, Portales-Casamar E, Wasserman WW, Maurin T, Mari B, Barbry P, Vallar L, Friederich E, Arar K, Cassinat B, Chomienne C, Lecellier CH.

Blood. 2009 Jan 8;113(2):412-21. doi: 10.1182/blood-2008-05-158139. Epub 2008 Oct 21.

12.

Crosstalk between xenobiotics metabolism and circadian clock.

Claudel T, Cretenet G, Saumet A, Gachon F.

FEBS Lett. 2007 Jul 31;581(19):3626-33. Epub 2007 Apr 17. Review.

13.

Anti-viral RNA silencing: do we look like plants?

Saumet A, Lecellier CH.

Retrovirology. 2006 Jan 12;3:3. Review.

14.

Type 3 repeat/C-terminal domain of thrombospondin-1 triggers caspase-independent cell death through CD47/alphavbeta3 in promyelocytic leukemia NB4 cells.

Saumet A, Slimane MB, Lanotte M, Lawler J, Dubernard V.

Blood. 2005 Jul 15;106(2):658-67. Epub 2005 Mar 22.

15.

Death receptor signaling regulatory function for telomerase: hTERT abolishes TRAIL-induced apoptosis, independently of telomere maintenance.

Dudognon C, Pendino F, Hillion J, Saumet A, Lanotte M, Ségal-Bendirdjian E.

Oncogene. 2004 Sep 30;23(45):7469-74.

PMID:
15326479

Supplemental Content

Loading ...
Support Center